CASI Pharmaceuticals Inc

NASDAQ:CASI   3:59:40 PM EDT
2.50
+0.08 (+3.31%)
Earnings Announcements

CASI Pharmaceuticals Announces Third Quarter 2020 Financial Results

Published: 11/09/2020 12:28 GMT
CASI Pharmaceuticals Inc (CASI) - Casi Pharmaceuticals Announces Third Quarter 2020 Financial Results.
Q3 Revenue $4.2 Million Versus $2.7 Million.
Increasing Evomela Full-year Revenue Guidance for 2020.
Qtrly Net Loss per Share $0.14.
Q3 Earnings per Share View $-0.06 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $4.45 Million
Adjusted EPS is expected to be -$0.07

Next Quarter Revenue Guidance is expected to be $4.1 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.